The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin

Edoxaban Management in Diagnostic and Therapeutic Procedures

NCT02950168 ·Status: COMPLETED

Anti-factor Xa Based Venous Thromboembolism Prophylaxis

NCT05221879 ·Status: COMPLETED ·Phase: NA

Edoxaban and Frailty in Senior Individuals

NCT03524924 ·Status: COMPLETED

Thromboprophylaxis in Critically Ill Patients

NCT00437697 ·Status: TERMINATED ·Phase: PHASE4

Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

NCT01153698 ·Status: TERMINATED

Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism

NCT02977013 ·Status: COMPLETED

Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery

NCT00847301 ·Status: COMPLETED

Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach

NCT00345618 ·Status: COMPLETED ·Phase: PHASE3

Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma

NCT03339349 ·Status: COMPLETED ·Phase: PHASE2

Enoxaparin in Acute Venous Thromboembolic Disease

NCT00265993 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

NCT00922766 ·Status: COMPLETED

AntiCoagulation Tracking InterVention and Evaluation

NCT04059965 ·Status: WITHDRAWN ·Phase: NA

Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients

NCT00311753 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients

NCT00375076 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

NCT02182024 ·Status: COMPLETED ·Phase: PHASE1

Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.

NCT01970280 ·Status: UNKNOWN ·Phase: PHASE4

anti10a Levels in Women Treated With LMWH in the Postpartum Period

NCT02856295 ·Status: COMPLETED ·Phase: PHASE4

Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.

NCT04710732 ·Status: TERMINATED ·Phase: PHASE4

Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function

NCT00264693 ·Status: COMPLETED

Dose Ranging Study in Elective Total Hip Replacement Surgery

NCT00338897 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

NCT01184989 ·Status: COMPLETED ·Phase: PHASE4

Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

NCT00396786 ·Status: COMPLETED ·Phase: PHASE2

Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty

NCT04878497 ·Status: UNKNOWN

Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry

NCT02362659 ·Status: COMPLETED

Reversal of the Antithrombotic Action of New Oral Anticoagulants

NCT01478282 ·Status: UNKNOWN ·Phase: PHASE4